Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation

Clinical and Experimental Immunology

Volumn 163, Issue 3, 2011, Pages 333-338

  Toossi, Z ^a,b   Hirsch, C S ^a   Wu, M ^a   Mayanja Kizza, H ^c,d,e   Baseke, J ^e   Thiel, B ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

^d Ugandan National Tuberculosis and Leprosy Programme   (Uganda)

^e JOINT CLINICAL RESEARCH CENTRE   (Uganda)

Author keywords

Cytokines; HIV; Regulatory T cells; Transforming growth factor ; Tuberculosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PLEURA FLUID; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYSTEMIC CIRCULATION; TUBERCULOUS PLEURISY;

ADULT; CYTOKINES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; FUSION PROTEINS, GAG-POL; GENE EXPRESSION; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PLASMA; PLEURAL CAVITY; PLEURAL EFFUSION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS, PLEURAL; VIRAL LOAD; YOUNG ADULT;

EID: 79551718159     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04269.x     Document Type: Article

References (31)

1. Dye C, Lonnroth K, Jaramillo E, Williams BG, Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ 2009; 87:683-91.
2. Richter C, Perenboom R, Mtoni I etal. Clinical features of HIV-seropositive and HIV-seronegative patients with tuberculous pleural effusion in Dar es Salaam, Tanzania. Chest 1994; 106:1471-5.
3. Toossi Z. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. J Infect Dis 2003; 188:1146-55.
4. Toossi Z, Johnson JL, Kanost RA etal. Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: potential mechanisms of viral activation. J Acquir Immune Defic Syndr 2001; 28:1-8.
5. Toossi Z, Mayanja-Kizza H, Baseke J etal. Inhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis. Clin Exp Immunol 2005; 142:327-32.
6. Collins KR, Quinones-Mateu ME, Wu M etal. Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity. J Virol 2002; 76:1697-706.
7. Lawn SD, Pisell TL, Hirsch CS, Wu M, Butera ST, Toossi Z. Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection. J Infect Dis 2001; 184:1127-33.
8. Douek DC, Picker LJ, Koup RA. T cell dynamics in HIV-1 infection. Annu Rev Immunol 2003; 21:265-304.
9. Akira S, Isshiki H, Sugita T etal. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1990; 9:1897-906.
10. An P, Vlahov D, Margolick JB etal. A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals. J Infect Dis 2003; 188:228-31.
11. Goletti D, Kinter AL, Coccia EM etal. Interleukin (IL)-4 inhibits phorbol-ester induced HIV-1 expression in chronically infected U1 cells independently from the autocrine effect of endogenous tumour necrosis factor-alpha, IL-1beta, and IL-1 receptor antagonist. Cytokine 2002; 17:28-35.
12. Li YG, Iwabu Y, Warachit J etal. Interleukin-4 up-regulates T-tropic human immunodeficiency virus type 1 transcription in primary CD4+ CD38+ T-lymphocyte subset. Microbiol Immunol 2005; 49:155-65.
13. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172:5149-53.
14. Yamazaki S, Bonito AJ, Spisek R, Dhodapkar M, Inaba K, Steinman RM. Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors. Blood 2007; 110:4293-302.
15. Eggena MP, Barugahare B, Jones N etal. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005; 174:4407-14.
16. Hryniewicz A, Boasso A, Edghill-Smith Y etal. CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 2006; 108:3834-42.
17. Ribeiro-Rodrigues R, Resende Co T, Rojas R etal. A role for CD4CD25 T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol 2006; 144:25-34.
18. Hirsch CS, Baseke J, Mayanja-Kizza H, Wu M, Boom WH, Toossi Z. T-regs and suppression of CD4 T-cell responses during HIV/TB (abstract). Am J Respir Med 2006; (Suppl.):173.
19. Tesseur I, Zou K, Berber E, Zhang H, Wyss-Coray T. Highly sensitive and specific bioassay for measuring bioactive TGF-beta. BMC Cell Biol 2006; 7:15.
20. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968; 97:77-89.
21. Hertoghe T, Wajja A, Ntambi L etal. T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB). Clin Exp Immunol 2000; 122:350-7.
22. Mayanja-Kizza H, Wu M, Aung H etal. The interaction of monocyte chemoattractant protein-1 and tumour necrosis factor-alpha in Mycobacterium tuberculosis-induced HIV-1 replication at sites of active tuberculosis. Scand J Immunol 2009; 69:516-20.
23. Yagi H, Nomura T, Nakamura K etal. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004; 16:1643-56.
24. Harashima A, Toraya T, Okochi A etal. Interleukin-8 and RANTES are signature cytokines made by HOZOT, a new type of regulatory T cells. Mol Immunol 2009; 46:3310-19.
25. Bezuidenhout J, Roberts T, Muller L, van Helden P, Walzl G. Pleural tuberculosis in patients with early HIV infection is associated with increased TNF-alpha expression and necrosis in granulomas. PLoS ONE 2009; 4:e4228.
26. Djoba Siawaya JF, Chegou NN, van den Heuvel MM etal. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis. Cytokine 2009; 47:132-6.
27. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in tuberculosis patients. Am J Respir Crit Care Med 2005; 173:803-10.
28. Chen X, Zhang M, Liao M etal. Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells. Am J Respir Crit Care Med 2010; 181:734-42.
29. Nakagome K, Okunishi K, Imamura M etal. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine. J Immunol 2009; 183:209-20.
30. Chaudhry A, Rudra D, Treuting P etal. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009; 326:986-91.
31. Prendergast A, Prado JG, Kang YH etal. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS 2010; 24:491-502.